1 |
MDCG 2019-9, Rev.0, Summary of safety and clinical performance A guide for manufacturers and notified bodies. 2019, pp. 21-24.
|
2 |
MFDS.「Regulations on In Vitro Diagnostic Medical Device Items and Classification by Item」. 2020, pp. 8-38.
|
3 |
ISO 13485:2016: Medical devices, Quality management systems - Requirements for regulatory purposes. 2016, pp. 6.
|
4 |
ISO 14971:2019: Medical devices, Application of risk management to medical devices. 2019, pp. 1-7.
|
5 |
ISO/TR 24971:2020: Medical devices, Guidance on the application of ISO 14971. 2020, pp. 63-85.
|
6 |
MEDDEV 2.12/1 Rev. 8, GUIDELINES ON A MEDICAL DEVICES VIGILANCE SYSTEM. 2013, pp. 13-26.
|
7 |
MEDDEV 2.12/2 Rev. 2, GUIDELINES ON MEDICAL DEVICES, POST MARKET CLINICAL FOLLOW-UP STUDIES, A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES. 2012, pp. 8-14.
|
8 |
Min Woo Kang. Risk management application plan according to ISO14971:2019-Analysis through risk management of VR medical devices. Medical Device Engineering and Management. The Graduate School, Yonsei University. 2020, pp. 10-13.
|
9 |
MDCG 2021-1, Rev.1, Guidance on harmonised administrative practices and alternative technical solutions until EUDAMED is fully functional. 2021, pp. 23.
|
10 |
ISO 14971:2007: Medical devices, Application of risk management to medical devices. 2007, pp. 1-5.
|
11 |
DIRECTIVE 98/79/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. 1998, pp. 25.
|
12 |
EU IVDR REGULATION (EU) 2017/746 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. 2017;65.
|
13 |
NB-MED/2.12/Rec1 - Post-Marketing Surveillance(PMS) post market/production MINISTRY DECREE. 2005;1-9.
|
14 |
MDCG 2020-7, Rev.0, Post-Market Clinical Follow-up (PMCF) Plan Template A guide for manufacturers and notified bodies. 2020, pp. 5-12.
|
15 |
MDCG 2020-8, Rev.0, Post-Market Clinical Follow-up (PMCF) Evaluation Report Template A guide for manufacturers and notified bodies. 2020, pp. 4-9.
|
16 |
MDITAC. Post-sales clinical follow-up care guidelines. 2012, pp. 4-6.
|
17 |
NIDS. Standard Trend Expert Newsletter, ISO 14971:2019 Major Revisions and Implications. 2020, pp. 4-11.
|
18 |
MFDS. 「In vitro diagnostic medical device manufacturing and quality control standards」. 2020, pp. 31.
|